Gomekli
mirdametinib · Capsule · Oral
No FDA structured label text is available for Gomekli. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Mirdametinib in 3 products
Gomekli NDC products (3)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 82448-130 | Mirdametinib 1 mg/1 Capsule | SpringWorks Therapeutics, Inc. | NDA |
| 82448-134 | Mirdametinib 1 mg/1 Tablet, For Suspension | SpringWorks Therapeutics, Inc. | NDA |
| 82448-260 | Mirdametinib 2 mg/1 Capsule | SpringWorks Therapeutics, Inc. | NDA |
Frequently asked questions
Who makes Gomekli?
Gomekli is listed by 1 labeler in the FDA NDC directory, including SpringWorks Therapeutics, Inc..